title: Pneumonia research in Papua New Guinea: 1967-1986.
abstract: Between 1967 and 1985 research on pneumonia in Papua New Guinea (PNG) was fundamental not only to standard treatments of disease in PNG, but also to the establishment of the World Health Organization's global Program for Control of Acute Respiratory Infections. Pneumonia was the leading cause of death in both population-based and hospital studies. Research that began in 1967 revealed a pattern of disease in adults reminiscent of that seen in industrialized countries in the early 20th century. Streptococcus pneumoniae (pneumococcus) was the predominant causative organism. Pneumococci were commensals of the upper respiratory tract that invaded first the lungs and then the blood stream. Some serotypes were more invasive than others and case fatality increased with deeper levels of invasion. The pandemic of Hong Kong (H3N2) influenza spread to the Southern Highlands in 1969 resulting in 2000 deaths. The conclusion that pneumococcal pneumonia had been the principal cause of death led to the establishment of a pneumonia research unit in Tari. A field trial of pneumococcal polysaccharide vaccine showed the vaccine to be most effective in preventing invasive disease. Vaccination reduced pneumonia mortality by 44% in previously healthy adults. The epidemiological situation was more complex in children than in adults because many different species and serotypes of bacteria could be isolated from lung aspirate. Although many of these organisms would normally have been regarded as non-pathogenic, S. pneumoniae and Haemophilus influenzae, recognized pathogens, were the principal causes of severe morbidity and mortality. The same principles of carriage of and invasion by upper respiratory commensals applied as much to children as they did to adults, and the rank order of invasive serotypes of S. pneumoniae and H. influenzae was the same in different age groups. Slow maturation of a child's immune system meant, however, that children could be susceptible to invasion by particular serotypes. Infants were frequently colonized by pathogenic bacteria within days of birth. Nasal discharge, which was extremely common, was most probably a result of domestic smoke pollution and low standards of hygiene. Aspiration of infected secretions was a likely explanation for the variety of organisms isolated from lung aspirate. A trial of pneumococcal polysaccharide vaccine showed the vaccine to be effective in preventing death from pneumonia in children 6-9 months of age provided pneumonia was not associated with other causes of death; this result was shown to be consistent with the principles of infection and invasion described above. Principles of antibiotic therapy for child pneumonia were also established at this time.
authors.affiliation: Australian Centre for International and Tropical Health, School of Population Health, University of Queensland, Brisbane, Australia. i.riley@uq.edu.au
authors.forename: Ian D
authors.initials: ID
authors.lastname: Riley
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000266:history; D035843:Biomedical Research / Q000266:history*; D002648:Child; D049673:History, 20th Century; D006801:Humans; D015994:Incidence; D010219:Papua New Guinea / Q000453:epidemiology; D022242:Pneumococcal Vaccines / Q000008:administration & dosage / Q000266:history; D011018:Pneumonia, Pneumococcal / Q000453:epidemiology / Q000266:history* / Q000517:prevention & control; D013296:Streptococcus pneumoniae / Q000472:pathogenicity
chemical_list: D000900:Anti-Bacterial Agents; D022242:Pneumococcal Vaccines